Wenrong Huang

Characterization of mutations in patients with autoimmune polyglandular syndrome type 1 (APS1)

Cong‐Yi Wang, Abdoreza Davoodi‐Semiromi, Wenrong Huang et al. · Human Genetics · 1998 · 136 citations

Life Sciences, Genetics, Molecular Genetics +12

Discovery of betrixaban (PRT054021), N-(5-chloropyridin-2-yl)-2-(4-(N,N-dimethylcarbamimidoyl)benzamido)-5-methoxybenzamide, a highly potent, selective, and orally efficacious factor Xa inhibitor

Penglie Zhang, Wenrong Huang, Lingyan Wang et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 108 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +7

1-(2-Naphthyl)-1 H -pyrazole-5-carboxylamides as potent factor Xa inhibitors. Part 3: Design, synthesis and SAR of orally bioavailable benzamidine-P4 inhibitors

Zhaozhong J. Jia, Yanhong Wu, Wenrong Huang et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 52 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +8

Inhibitory effect of carboxylic acid group on hERG binding

Bing‐Yan Zhu, Zhaozhong J. Jia, Penglie Zhang et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 51 citations · Full text

Pharmacy, Biochemistry, Medicinal Chemistry +8

Similar outcomes after haploidentical transplantation with post-transplant cyclophosphamide versus HLA-matched transplantation: a meta-analysis of case-control studies

Zhenyang Gu, Li Wang, Lei Yuan et al. · Oncotarget · 2017 · 48 citations · Full text

Medicine, Hematology, Immunology +12